110 related articles for article (PubMed ID: 6481789)
1. Studies of natural killer cells in pregnancy. II. The immunoregulatory effect of pregnancy substances.
Toder V; Nebel L; Elrad H; Blank M; Durdana A; Gleicher N
J Clin Lab Immunol; 1984 Jul; 14(3):129-33. PubMed ID: 6481789
[TBL] [Abstract][Full Text] [Related]
2. Studies of natural killer cells in pregnancy. I. Analysis at the single cell level.
Toder V; Nebel L; Gleicher N
J Clin Lab Immunol; 1984 Jul; 14(3):123-7. PubMed ID: 6207299
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
Bonavida B; Lebow LT; Bradley TP
J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
[TBL] [Abstract][Full Text] [Related]
4. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of diminished natural killer cell activity in pregnant women and neonates.
Baley JE; Schacter BZ
J Immunol; 1985 May; 134(5):3042-8. PubMed ID: 3980989
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cells in normal pregnancy: analysis using monoclonal antibodies and single-cell cytotoxicity assays.
Gregory CD; Lee H; Rees GB; Scott IV; Shah LP; Golding PR
Clin Exp Immunol; 1985 Oct; 62(1):121-7. PubMed ID: 3864569
[TBL] [Abstract][Full Text] [Related]
7. Abnormal natural killer cell activity in systemic lupus erythematosus: an intrinsic defect in the lytic event.
Katz P; Zaytoun AM; Lee JH; Panush RS; Longley S
J Immunol; 1982 Nov; 129(5):1966-71. PubMed ID: 7119439
[TBL] [Abstract][Full Text] [Related]
8. Deficient natural killer cell function in preeclampsia.
Alanen A; Lassila O
Obstet Gynecol; 1982 Nov; 60(5):631-4. PubMed ID: 6183628
[TBL] [Abstract][Full Text] [Related]
9. In vitro enhancement of peripheral blood mononuclear cell natural killer activity following short term incubation with fetal calf serum.
Lauer SJ; Finlan J; Borella LD; Piaskowski VD; Casper JT
J Clin Lab Immunol; 1983 Oct; 12(2):105-10. PubMed ID: 6606047
[TBL] [Abstract][Full Text] [Related]
10. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
11. [Heterogeneity of a KU-2 cell line derived from human renal cell carcinoma--differential susceptibilities of its sublines to NK cell-mediated cytotoxicity].
Hayakawa M; Osawa A; Nagakura K; Kikuchi H
Hinyokika Kiyo; 1985 May; 31(5):763-8. PubMed ID: 4050622
[TBL] [Abstract][Full Text] [Related]
12. A single cell marker of active NK cytotoxicity: only a fraction of target binding lymphocytes are killer cells.
Targan S; Grimm E; Bonavida B
J Clin Lab Immunol; 1980 Nov; 4(3):165-8. PubMed ID: 7205938
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human natural killer activity by 2-deoxy-D-glucose and other sugars.
Schlesinger M; Bekesi JG
J Clin Lab Immunol; 1984 Sep; 15(1):19-26. PubMed ID: 6512844
[TBL] [Abstract][Full Text] [Related]
14. A novel telomerase-based approach to detect natural cell-mediated cytotoxic activity against tumor cells in vitro.
Faraoni I; Cottarelli A; Giuliani A; Bonmassar L; Rossi L; Bonmassar E
J Immunol Methods; 2005 Oct; 305(2):162-72. PubMed ID: 16165149
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
Gan X; Zhang L; Solomon GF; Bonavida B
Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
[TBL] [Abstract][Full Text] [Related]
16. 2',5'-Oligoadenylate trimer core and the cordycepin analog augment the tumoricidal activity of human natural killer cells.
Black PL; Henderson EE; Pfleiderer W; Charubala R; Suhadolnik RJ
J Immunol; 1984 Nov; 133(5):2773-7. PubMed ID: 6332860
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
Neville ME; Hiserodt JC
J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
[TBL] [Abstract][Full Text] [Related]
18. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
Wright SC; Weitzen ML; Kahle R; Granger GA; Bonavida B
J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762
[TBL] [Abstract][Full Text] [Related]
19. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
Condiotti R; Nagler A
Exp Hematol; 1998 Jul; 26(7):571-9. PubMed ID: 9657131
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cell activity and autologous tumor killing activity in cancer patients: overlapping involvement of effector cells as determined in two-target conjugate cytotoxicity assay.
Uchida A; Yanagawa E
J Natl Cancer Inst; 1984 Nov; 73(5):1093-100. PubMed ID: 6593485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
